NASDAQ · SLP

Simulations Plus, Inc.

$18.34 +$0.01 (+0.05%) 1D Market open

Key Metrics

$370.72M
Market cap
45.74×
P/E · TTM
$82.06M
Revenue · TTM
$8.11M
Net income
EPS · TTM $0.40
Dividend yield
Free cash flow $24.54M
Beta · 1Y 1.11
EBITDA · TTM $11.80M
Gross margin 63.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 16
    The stock moved +11.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 16
  • May 11
    The stock moved -11.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11
  • Mar 30
    From its Jan 29 high, the share price fell 36%.

    Peak close $17.71 on Jan 29; trough close $11.36 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$370.72M
Enterprise value
Shares outstanding20.2M
52-wk range$11.09 – $21.01
Avg volume · 20D217.4K
Net cash
Book value / share$6.87
IndustryServices-Computer Integrated Systems Design
ExchangeNASDAQ
About Simulations Plus, Inc.
IPO dateJun 18, 1997
Employees213

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E45.74
P/S4.52
P/FCF15.11
EV/EBITDA
EV/Sales
Graham №$7.87

Profitability

Gross 63.4%
Operating 14.0%
Net 9.9%
FCF 29.9%
ROE / ROIC 5.0% · 8.3%

Financial Health

Current ratio5.54
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$61.56M

Cash Flow · TTM

Operating CF $24.94M
Capex −$403.00K
Free cash flow $24.54M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

17.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$7.87 vs $18.34
Trades 2.3× above classic defensive value — priced for growth
Fundamentals through 2026-05-31 · computed by TickerWolf from SEC filings